• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Evaluation of aqueous extracts of Cistanche deserticola as a polysaccharide adjuvant for seasonal influenza vaccine in young adult mice

tetano

Editor, Senior Moderator
Immunol Lett. 2019 Jul 8. pii: S0165-2478(19)30206-8. doi: 10.1016/j.imlet.2019.07.002. [Epub ahead of print]
[h=1]Evaluation of aqueous extracts of Cistanche deserticola as a polysaccharide adjuvant for seasonal influenza vaccine in young adult mice.[/h] Zhao B[SUP]1[/SUP], Lian J[SUP]2[/SUP], Wang D[SUP]3[/SUP], Li Q[SUP]1[/SUP], Feng S[SUP]1[/SUP], Li J[SUP]1[/SUP], Zhang A[SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Adjuvants can improve the efficacy of influenza vaccines and are still a hot spot in the study and development of influenza vaccines. In this report, the effects of aqueous extracts of Cistanche deserticola (AECD) as a polysaccharide adjuvant on seasonal influenza vaccines (IVV) were explored. The experimental data of anti-IVV IgG[SUB]1[/SUB] and IgG as well as hemagglutinin inhibition (HI) titers in young adult mice indicated that IVV intramuscularly co-injected with AECD was significantly more immunogenic than alum-adjuvanted or non-adjuvanted IVV. AECD-adjuvanted vaccine could rapidly initiate specific IgG response. Similarly, IVV with AECD augmented significantly lymphocyte proliferation and increased the positive rates of CD4[SUP]+[/SUP], CD8[SUP]+[/SUP] and CD44[SUP]+[/SUP] T cells from draining lymph nodes and spleens. Importantly, IVV with AECD could induce the Th1 immune response, as indicated by higher IgG[SUB]2a[/SUB] levels accompanied by the induction of IFN-γ in CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T cells. Additionally, IVV with AECD activated dendritic cells (DCs) and decreased the expression of Treg cells. There were no noticeable side effects after the vaccination. In brief, the addition of AECD enhanced immunogenicity to seasonal influenza vaccine by the induction of HI antibody generation, more rapid humoral immune responses, and a balanced Th1-/Th2-type response, effective T-cell responses, which may be important for seasonal influenza vaccines with broad and long lasting immunity.
Copyright ? 2019. Published by Elsevier B.V.


[h=4]KEYWORDS:[/h] Aqueous extract; Cistanche deserticola; Influenza vaccine; Polysaccharide adjuvant; Th1/Th2 response

PMID: 31295429 DOI: 10.1016/j.imlet.2019.07.002
 
Back
Top Bottom